Professional Documents
Culture Documents
CC:
TRIAGE
ER Normal Value
BP 120/70 90/60 mm/Hg to 120/80 mm/Hg
Temp 38.8 36.5 37.6
Pulse Rate 130 60-100
Respiratory Rate 33 12-18
O2 saturation 97
ESI CATEGORY 2
PRIMARY SURVEY
Airway patent
Dyspneic
Tachypneic O2 via face mask
Basal rales at 10 lpm
O2 sat: 97
PRIMARY SURVEY
ABG
Attach to cardiac monitor
(+) pallor Chest Xray
(-) cyanosis ECG
Start IV: PNSS 1L FD 300 cc now
then 100 cc/hr
GCS 15
E4V5M6
PRIMARY SURVEY
(+) pallor
(+) Dyspnea Attach to cardiac monitor
(+) fever Chest Xray, ABG, ECG, CBG
(+) hematemesis Start IV: PNSS 1L FD 300 cc now then 100 cc/hr
(+) epigastric pain Medications for fever & epigastric pain were given
Labs were requested
SECONDARY SURVEY
No known food and drug allergies
PTU (compliant)
1 mo PTC:
patient started experiencing epigastric pain, heat intolerance,
anorexia, and palpitations no consultation was done during this time
History of Present Illness
10 days PTC:
epigastric pain started to worsen associated with fever and palpitations thus consult in
this institution
Patient was admitted and was started on PTU maintenance patient was then discharged
after 3
5 days PTC:
Recurrence of epigastric pain associated with on and off fever, heat intolerance, diarrhea,
anorexia, dyspnea and palpitations and melena. These symptoms persisted thus consult
Day of consult:
While the patient was on her way to the hospital patient loss consciousness and vomited
coffee ground vomitus
Personal History
No trauma
(-) Hypertension
(-) Diabetes Mellitus
(-) Bronchial Asthma
(-) Cardiac problems
(-) Renal Problems
Family History
No Family History of:
Stroke
Heart disease
Diabetes mellitus
Tuberculosis
Cancer
Hypertension
Asthma
Personal/ Social History
Civil Status: Married
Occupation: market vendor
Educational Profile: HS grad
Lifestyle habits:
Non-smoker
Non-alcoholic beverage drinker
No history of substance abuse
Review of Systems
(+) Nausea
(-) Weight Loss
(-) Bowel Changes
(-) Night Sweats
(-) Chills
Physical Exam
General Survey:
awake, conscious, coherent, in cardiopulmonary distress,
agitated
Fever No Hypotension
Difficulty of breathing
Nausea and vomiting
Tachycardia
Agitation
BPUD
RULE IN RULE OUT
Parameter PE Score
Temperature 38.8 15
CNS Agitated 10
GI-hepatic function Abdominal pain 10
Cardiovascular Tachycardia at 130 bpm 15
6:15 pm:
PTU 15 mg tab x 12 tab now
Propanolol 40 mg/tab 1 tab now
Hydrocortisone 100 mg IVTT now
Start Omperazole 80 mg + 80 cc PNSS to run at 10 cc/hr
Labs:
CBC, platelet, UA, serum Na, serum K, Ca, Mg, BUN,
Crea, APTT, PT, Trop I, CKMB, TSH, FT4, FT3, chest xray
Sinus tachycardia
ABG
Metabolic alkalosis,
partly compensated
Hyperoxygenation
DISCUSSION
THYROID GLAND
Thyroid hormone affects all organ systems and is responsible
for increasing metabolic rate, heart rate, and ventricle
contractility, as well as muscle and central nervous system
excitability.
Two major types
Thyroxine - is the major form of thyroid hormone.
Triiodothyronine - more potent
THYROTOXICOSIS or THYROID STORM
- A life threatening exacerbation of Hyperthyroidism
ADRENERGIC
PRECIPITATING EXCESSIVE
HYPERACTIVITY
CONDITION OR THYROID
EVENT HORMONES
ALTERED PERIPHERAL
RESPONSE
THYROTOXICOSIS or THYROID STORM
THYROTOXICOSIS or THYROID STORM
PRECIPITATING FACTORS
Burch Wartofskys Scoring
Burch Wartofskys Scoring
Burch Wartofskys Scoring
TREATMENT
RATIONALE: Inhibition of thyroid gland synthesis of new thyroid hormone with a
thionamide should be initiated before iodine therapy to prevent the stimulation of new
thyroid hormone synthesis that can occur if iodine is given too soon.
1. Supportive care
2. Inhibition of new hormone synthesis
3. Inhibition of thyroid hormone release
4. Peripheral -adrenergic receptor blockade
5. Preventing peripheral conversion of thyroxine to triiodothyronine
SUPPORTIVE CARE
Fluid replacement
Methimazole Propylthiouracil
Dosage:
Longer half life than PTU
600 to 1000mg is given PO as loading dose
Presents in free form in the serum
200 to 250mg every 4 hours as
Dosage:
maintenance dose
40 to 100mg given PO as loading dose
Total daily dose: 1200 to 1500mg/day
20mg every 4 hours as maintenance
dose
120mg/day maximum dose per day
Inhibition of Hormone Release
Iodine
Thionamide therapy must be instituted FIRST
It blocks the release of prestored hormone
Decreases iodide transport and oxidation in follicular cells
Lugol solution, potassium iodide, ipodate or lithium carbonate
Preventing peripheral conversion of thyroxine to
triiodothyronine
PTU
Propanolol
Glucocorticoids
- hydrocortisone or dexamethasone are essential
in treatment
Improves survival rates
Given for patients with severe thyrotoxicosis in
conjuntion with hypotension
Beta-adrenergic receptor blockade
Propanolol
Given in slow 1 to 2mg boluses which maybe repeated every 10 to 15 minutes
until the desired effect is achieved
Oral dosage
20 to 120mg per dose or 160 to 320mg/day in divided doses
THANK YOU